01 January 2008
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. EhrdhardAnn Transplant 2008; 13(1): 36-37 :: ID: 880195
Abstract
Background: Liquid chromatography-tandem mass spectrometry (LC/MS/MS) is a powerful technique for the simultaneous determination of cyclosporin A, tacrolimus, sirolimus and everolimus in whole blood. LC/MS/MS has the benefits of lower detection limits, greater specificity and a broader dynamic range than commercial immunoassays. This paper evaluates the use of a commercially available kit from Recipe GmbH of whole blood calibrators and controls with a quick and simple sample preparation method for LC/MS/MS determination of four immunosuppressants.
Material/Methods: Samples were prepared by adding 200 μL of protein precipitation reagent containing internal standards to 100 μL of whole blood (unknown, calibrators and controls). Samples were then vortexed and centrifuged. Two-dimensional chromatography was performed on the supernatant, with detection by LC/MS/MS using multiple reaction monitoring (MRM) in positive mode. Mass spectrometer parameters were optimized for each analyte.
Results: The whole blood calibrator kit contained 7 calibrators including a blank. The LC/MS/MS assay showed excellent linearity over the concentration range with calibration regression coefficient ranging from 0.9994 to 0.9998. The intra-assay accuracy and precision was within the 20% cutoff, with the exception of the lowest concentration calibrator. Inter-assay accuracy ranged from 89-102% for the low concentration quality control, with % CVs ranging from 5.5-17%. Unknown sample results show good correlation with results obtained from a separate laboratory that prepares their own calibrators and controls in-house.
Conclusions: This study has demonstrated the successful use of a commercially available kit for whole blood calibrators and controls for the determination of four immunosuppressants in unknown samples by LC/MS/MS.
Keywords: Chromatography, immunosuppressants, Sirolimus
In Press
07 Mar 2024 : Original article
Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World ...Ann Transplant In Press; DOI: 10.12659/AOT.942167
07 Mar 2024 : Original article
Outcomes of Renal Transplantation in ANCA-Associated VasculitisAnn Transplant In Press; DOI: 10.12659/AOT.943433
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860